Insider Trading29 Sept 2026, 05:30 pm
Aarti Drugs Closes Trading Window for Q2 FY27 Results
AI Summary
Aarti Drugs Ltd has announced the closure of its trading window in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015. The window will be shut from October 1, 2026, until 48 hours after the declaration of the financial results for the quarter and half-year ended September 30, 2026. This measure is standard practice to prevent insider trading during sensitive financial reporting periods.
Key Highlights
- Trading window closed from October 1, 2026.
- Closure is for Q2 and H1 FY27 financial results.
- Window reopens 48 hours post-results declaration.
- Aims to prevent insider trading.
- Standard corporate governance practice.
Price Impact
More from AARTIDRUGS